Sensus Healthcare, Inc (SRTS) Stock Price

SRTSStock

$3.52+6.67%52W

Market Cap$57.95M

P/E9.63x

PEG Ratio—

Div yield—

Beta1.19

SRTS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-20.26%

Price vs S&P 500 (4W)19.01%

VGM Score53.28

P/E Ratio (Annual)9.63x

P/CF (Annual)97.74x

Book Value / Share (Quarterly)$2.77

P/TBV (Annual)2.57x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-14.86%

Cash Flow / Share (Quarterly)$-0.04

Price vs S&P 500 (YTD)-24.38%

Gross Margin (TTM)37.74%

Net Profit Margin (TTM)-34.50%

EPS (TTM)$-0.47

10-Day Avg Trading Volume0.05M

EPS Excl Extra (TTM)$-0.47

Revenue Growth (5Y)23.46%

EPS (Annual)$-0.47

ROI (Annual)-16.05%

Gross Margin (Annual)43.18%

Net Profit Margin (5Y Avg)11.90%

Cash / Share (Quarterly)$1.11

Revenue Growth QoQ (YoY)-59.32%

P/E Normalized (Annual)9.63x

ROA (Last FY)-14.55%

Revenue Growth TTM (YoY)-42.94%

EBITD / Share (TTM)$-0.71

ROE (5Y Avg)12.62%

Operating Margin (TTM)-53.34%

Cash Flow / Share (Annual)$0.02

P/B Ratio1.13x

P/B Ratio (Quarterly)1.44x

Net Income / Employee (Annual)$-128,700

EV / Revenue (TTM)1.48x

Net Interest Coverage (TTM)-100.00x

ROA (TTM)-14.02%

EV / EBITDA (TTM)12.04x

EPS Incl Extra (Annual)$-0.47

Current Ratio (Annual)9.72x

Quick Ratio (Quarterly)4.03x

3-Month Avg Trading Volume0.05M

52-Week Price Return6.67%

EV / Free Cash Flow (Annual)100.25x

Revenue / Employee (TTM)$375,500

Tangible BV / Share (Quarterly)$2.72

P/S Ratio (Annual)1.88x

Asset Turnover (Annual)0.52x

52-Week High$5.49

Operating Margin (5Y Avg)5.76%

EPS Excl Extra (Annual)$-0.47

CapEx CAGR (5Y)-11.45%

Tangible BV CAGR (5Y)33.89%

26-Week Price Return-8.33%

Quick Ratio (Annual)6.31x

13-Week Price Return10.69%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)7.27x

Enterprise Value$33.28M

Revenue / Share Growth (5Y)23.62%

Asset Turnover (TTM)0.41x

Book Value / Share Growth (5Y)17.51%

Revenue / Employee (Annual)$458,000

Inventory Turnover (Annual)1.06x

Pretax Margin (Annual)-35.02%

Cash / Share (Annual)$1.34

3-Month Return Std Dev48.94%

Gross Margin (5Y Avg)57.72%

Net Income / Employee (TTM)$-129,500

ROE (Last FY)-16.05%

Net Interest Coverage (Annual)-27.22x

EPS Basic Excl Extra (Annual)$-0.47

P/FCF (TTM)9.59x

Receivables Turnover (TTM)2.09x

EV / Free Cash Flow (TTM)93.64x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.47

Receivables Turnover (Annual)2.13x

ROI (TTM)-15.79%

P/S Ratio (TTM)2.29x

Pretax Margin (5Y Avg)13.47%

Revenue / Share (Annual)$1.68

Tangible BV / Share (Annual)$2.93

Price vs S&P 500 (52W)-11.89%

Year-to-Date Return-11.56%

5-Day Price Return0.86%

EPS Normalized (Annual)$-0.47

ROA (5Y Avg)10.51%

Net Profit Margin (Annual)-28.09%

Month-to-Date Return20.96%

Cash Flow / Share (TTM)$-0.04

EBITD / Share (Annual)$-0.61

EPS Growth (3Y)17.62%

Operating Margin (Annual)-37.50%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)100.71x

ROI (5Y Avg)12.62%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.47

P/TBV (Quarterly)1.00x

P/B Ratio (Annual)1.36x

Inventory Turnover (TTM)0.81x

Pretax Margin (TTM)-50.57%

Book Value / Share (Annual)$2.92

Price vs S&P 500 (13W)8.74%

Beta1.19x

P/FCF (Annual)155.45x

Revenue / Share (TTM)$1.37

ROE (TTM)-15.79%

52-Week Low$2.66

vGradeB

gGradeD

mGradeB

vgmGradeC

SRTS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$0.11	-$0.53	-381.82%(-$0.42)
Q1 2026	May 7, 2026	-$0.11	-$0.16	-45.45%(-$0.05)
Q4 2025	Feb 12, 2026	-$0.06	-$0.19	-245.45%(-$0.14)
Q3 2025	Nov 6, 2025	-$0.11	-$0.06	+45.45%(+$0.05)
Q2 2025	Aug 7, 2025	$0.01	-$0.06	-700.00%(-$0.07)

SRTS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.10

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
SRTSSensus Healthcare, Inc	B	D	B	$3.52
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55

About Sensus Healthcare, Inc

Sensus Healthcare manufactures superficial radiotherapy (SRT) systems for treating skin cancers and non-cancerous skin conditions. The company's products, including the SRT-100 and SRT-100 Vision platforms, address dermatological applications such as basal cell carcinoma, squamous cell carcinoma, and keloids. Revenue is generated primarily from U.S. customers.